• Nenhum resultado encontrado

THE AUTHORS’ REPLY THE TREATMENT OF CHAGAS DISEASE PATIENTS WITH NITRODERIVATIVE IS UNSATISFACTORY

N/A
N/A
Protected

Academic year: 2019

Share "THE AUTHORS’ REPLY THE TREATMENT OF CHAGAS DISEASE PATIENTS WITH NITRODERIVATIVE IS UNSATISFACTORY"

Copied!
7
0
0

Texto

Loading

Imagem

Fig. 1 - Histopathological lesions in benznidazole treated rabbit. A: Malignant non-Hodgkin’s lymphoma invading the kidney

Referências

Documentos relacionados

In Argentina, there are periodic ILT outbreaks, especially in areas with high density of industrial poultry farms with poor management and biosecurity measures, in farms that

The probability of attending school four our group of interest in this region increased by 6.5 percentage points after the expansion of the Bolsa Família program in 2007 and

Effect of the treatment on the evolution of Chagas disease Since 1969 several therapeutic experiences have been performed in acute and chronic cases of Chagas disease using

Evidence for the benefit of aetiological treatment in patients with chronic Chagas disease - Until the BEN- znidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT)

for the treatment of Chagas disease should fulfill several requirements: ( i ) The drug should show parasitological cure for both the acute and the chronic phase; ( ii ) it has to

Chagas' disease reactivation occurred in three patients (16.6%): the direct examination of the buffy coat evidenced parasites and, clinically, the patients presented acute

pylori infection and the gastric histological and endoscopic features of chagasic and non-chagasic patients and of chagasic patients with the digestive form of Chagas disease

Therefore, the present study evaluated respiratory musculature among patients with Chagas disease, and the possible associations of indeterminate chronic Chagas disease with